Departmental Papers (Dental)

Document Type

Journal Article

Date of this Version

5-18-2016

Publication Source

Current Medical Research and Opinion

Volume

32

Issue

8

Start Page

1455

Last Page

1456

DOI

10.1080/03007995.2016.1185401

Abstract

Dental management of osteoporosis patients on anti-resorptive therapy can be challenging for both the dentist and physician because of the risk of osteonecrosis of the jaw (ONJ). This editorial reflects on the paper written by Tagushi et al that expressed a relative lack of communication between health care providers when treating osteoporosis patients. Osteoporosis-related bone fractures can be debilitating and occasionally lethal, but management with anti-resorptives is vital while cognizant of the complication of ONJ that can also negatively impact patient’s quality of life.

Copyright/Permission Statement

This is an Accepted Manuscript of an article published by Taylor & Francis in [Current Medical Research and Opinion] [May 18 2016], available online: http://www.tandfonline.com/10.1080/03007995.2016.1185401

Keywords

Osteoporosis, anti-resorptive therapies, osteonecrosis of the jaw, bisphosphonates, communication between physicians and dentists

Included in

Dentistry Commons

Share

COinS
 

Date Posted:02 August 2018

This document has been peer reviewed.